Cerebrospinal Fluid ?"-Amyloid1-42 Levels in the Differential Diagnosis of Alzheimer's Disease - Systematic Review and Meta-Analysis

Mo, J
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
2014Nov ; 17 ( 7 ) :A391.
PMID : 27200905
ÀúÀÚ »ó¼¼Á¤º¸
Mo, J - National Evidence-based Health Care Collaborating Agency & Inha University, SEOUL, South Korea.
ABSTRACT
na
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Reduced CSF Ab 1?2 levels are of potential utility in the differential diagnosis of AD versus non-AD dementias and healthy controls.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1016/j.jval.2014.08.860
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå